Cardiovascular Health Topics

The On-Topic Netowork

Cardiovascular Health > Atrial Fibrillation

The following information is about Atrial Fibrillation.

Atrial Fibrillation Defined

An irregular heart rhythm caused by an uncontrolled or chaotic contraction of the atria, the upper chambers of the heart. (See How the Heart Works: Heart Chambers.) This is a common rhythm problem after injury, surgery or irritability of the heart muscle. In some cases, the heart rhythm may return to normal by itself or with medication. Cardioversion may also be done by a physician to return the heart to its regular rhythm. (Read more)

This definition is in context to Cardiovascular Health. See more contextual defintions for Atrial Fibrillation.


Navigation: [ 1 2 3 4 5 Next ]

Sanofi Drug for Heart Rhythm Disorder Is Approved

Published July 3, 2009, 9:36 am, New York Times

Sanofi plans to begin marketing Multaq, generically known as dronedarone, in the United States this summer.

Full Story


FDA Approves Multaq(R) For Patients With Atrial Fibrillation Or Atrial Flutter

Published July 3, 2009, 5:07 am, Medical News Today

Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced that the U.S. Food and Drug Administration (FDA) has approved Multaq(R) (dronedarone) 400 mg Tablets. Patients with atrial fibrillation (AF) or atrial flutter (AFL) soon will have a new treatment option to help improve current management of their disease.

Full Story


What's Happening

Published July 3, 2009, 2:46 am, Arizona Range News

Secure pets during fireworks, thunder The Willcox DPS Humane Division remindes pet owners to please secure your yards to keep your animals safe during fireworks and monsoon season.

Full Story


*vwd/BUSINESS WIRE: Sorin Group Announces Regulatory Approval and First Implants of New-Platform FACIL and REPLY ...

Published July 2, 2009, 10:48 pm, vwd.de

MITTEILUNG UEBERMITTELT VON BUSINESS WIRE. FUER DEN INHALT IST ALLEIN DAS BERICHTENDE UNTERNEHMEN VERANTWORTLICH.

Full Story


Sanofi-aventis' Multaq receives US FDA nod to treat patients with atrial fibrillation or atrial flutter

Published July 2, 2009, 10:48 pm, PharmaBiz

Sanofi-aventis announced that the US Food and Drug Administration (FDA) has approved Multaq (dronedarone) 400 mg tablets.

Full Story


Sorin Group Announces Regulatory Approval and First Implants of New-Platform FACIL and REPLY Pacemakers in Japan

Published July 2, 2009, 10:30 pm, Business Wire via Yahoo! Finance

TOKYO----Sorin Group, , a global medical device company and a leader in the treatment of cardiovascular diseases, announced today the Ministry of Health, Labor and Welfare approval to market the FACIL™ and REPLY™ families of dual and single chamber rate responsive pacemakers.

Full Story


FDA approves Multaq tablets (dronedarone) to treat atrial fibrillation

Published July 2, 2009, 5:12 pm, News-Medical-Net

The U.S. Food and Drug Administration has approved Multaq tablets (dronedarone) to help maintain normal heart rhythms in patients with a history of atrial fibrillation or atrial flutter (heart rhythm disorders). The drug is approved to be used in patients whose hearts have returned to normal rhythm or who will undergo drug or electric-shock treatment to restore a normal heart beat.

Full Story


Sanofi-Aventis arrhythmia drug Multaq approved

Published July 2, 2009, 3:45 pm, INO News

(AP:TRENTON, N.J.) Sanofi-Aventis SA said Thursday its drug Multaq, which treats irregular heart rhythms, received marketing approval from the Food and Drug Administration, which turned it down three years ago.

Full Story


Sanofi-Aventis arrhythmia drug Multaq approved

Published July 2, 2009, 9:58 am, INO News

(AP:NEW YORK) Sanofi-Aventis SA said Thursday its drug Multaq, which treats irregular heart rhythms, received marketing approval after a delay of nearly three years.

Full Story


(AFX UK Focus) 2009-07-02 17:33 UPDATE 4-Sanofi wins FDA approval for heart drug Multaq

Published July 2, 2009, 9:52 am, Interactive Investor

By Caroline Jacobs

Full Story


Navigation: [ 1 2 3 4 5 Next ]

Are you looking for additional Cardiovascular Health > Atrial Fibrillation news? Try our new "Atrial Fibrillation News Focus" area.

If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Atrial Fibrillation. If you would like to find related tags we recommend Tag Patterns > Atrial Fibrillation

Off-site Atrial Fibrillation Research Links

If you still need additional information on Atrial Fibrillation then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Cardiovascular Health

If you know the Cardiovascular Health Term Name use the links below to quickly jump to your desired focus.



Bookmark Us

The On Topic Network

This website is part of The On Topic Network.

Thank You

Cardiovascular-Health.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.

License

Creative Commons License This work is licensed under Creative Commons.


Your Ad Here
Your Ad Here

Powered by Odin Assemble 2.5a